REMUS
Start SIP
Invest Now
Start SIP in REMUS
Performance
- Low
- ₹734
- High
- ₹740
- 52 Week Low
- ₹611
- 52 Week High
- ₹1,289
- Open Price₹740
- Previous Close₹742
- Volume400
Investment Returns
- Over 1 Month + 12.19%
- Over 3 Month -5.59%
- Over 6 Month -21.93%
- Over 1 Year -37.78%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.8
- PEG Ratio
- -
- Market Cap Cr
- 865
- P/B Ratio
- 2.8
- Average True Range
- 34.64
- EPS
- 24.53
- Dividend Yield
- 0.1
- MACD Signal
- 0.98
- RSI
- 53.84
- MFI
- 61.45
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹734.00
-8
(-1.08%)
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹719.33
- 50 Day
- ₹729.31
- 100 Day
- ₹775.35
- 200 Day
- ₹852.78
Resistance and Support
735.98
- R3 743.92
- R2 741.93
- R1 737.97
- S1 732.02
- S2 730.03
- S3 726.07
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results & Interim Dividend | |
| 2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-05-16 | Audited Results | |
| 2024-04-23 | Bonus issue & Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹734 As on 26 December, 2025 | 07:43
The Market Cap of Remus Pharmaceuticals is ₹864.9 Cr As on 26 December, 2025 | 07:43
The P/E ratio of Remus Pharmaceuticals is 29.8 As on 26 December, 2025 | 07:43
The PB ratio of Remus Pharmaceuticals is 2.8 As on 26 December, 2025 | 07:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.